Foresters Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $5.6M | Hold |
105,040
| – | – | 0.11% | 239 |
|
2019
Q2 | $5.26M | Hold |
105,040
| – | – | 0.09% | 266 |
|
2019
Q1 | $5.49M | Buy |
105,040
+22,840
| +28% | +$1.19M | 0.1% | 267 |
|
2018
Q4 | $3.93M | Sell |
82,200
-800
| -1% | -$38.2K | 0.07% | 292 |
|
2018
Q3 | $4.17M | Sell |
83,000
-6,480
| -7% | -$325K | 0.07% | 316 |
|
2018
Q2 | $4.51M | Buy |
89,480
+32,880
| +58% | +$1.66M | 0.08% | 282 |
|
2018
Q1 | $2.76M | Hold |
56,600
| – | – | 0.05% | 307 |
|
2017
Q4 | $2.51M | Buy |
56,600
+400
| +0.7% | +$17.7K | 0.04% | 317 |
|
2017
Q3 | $2.85M | Buy |
56,200
+560
| +1% | +$28.4K | 0.05% | 293 |
|
2017
Q2 | $3M | Sell |
55,640
-640
| -1% | -$34.5K | 0.05% | 293 |
|
2017
Q1 | $2.97M | Buy |
56,280
+960
| +2% | +$50.6K | 0.05% | 272 |
|
2016
Q4 | $2.65M | Buy |
55,320
+640
| +1% | +$30.7K | 0.05% | 283 |
|
2016
Q3 | $2.95M | Buy |
54,680
+640
| +1% | +$34.5K | 0.05% | 268 |
|
2016
Q2 | $2.93M | Buy |
54,040
+4,080
| +8% | +$221K | 0.06% | 267 |
|
2016
Q1 | $2.53M | Hold |
49,960
| – | – | 0.05% | 263 |
|
2015
Q4 | $2.52M | Hold |
49,960
| – | – | 0.05% | 262 |
|
2015
Q3 | $2.4M | Hold |
49,960
| – | – | 0.05% | 268 |
|
2015
Q2 | $2.6M | Buy |
49,960
+8,040
| +19% | +$419K | 0.05% | 276 |
|
2015
Q1 | $2.42M | Buy |
41,920
+8,000
| +24% | +$461K | 0.05% | 266 |
|
2014
Q4 | $1.81M | Sell |
33,920
-12,000
| -26% | -$641K | 0.04% | 265 |
|
2014
Q3 | $2.64M | Sell |
45,920
-8,000
| -15% | -$460K | 0.06% | 241 |
|
2014
Q2 | $3.61M | Hold |
53,920
| – | – | 0.07% | 230 |
|
2014
Q1 | $3.6M | Hold |
53,920
| – | – | 0.08% | 232 |
|
2013
Q4 | $3.6M | Hold |
53,920
| – | – | 0.08% | 221 |
|
2013
Q3 | $3.38M | Sell |
53,920
-16,000
| -23% | -$1M | 0.08% | 214 |
|
2013
Q2 | $4.37M | Buy |
+69,920
| New | +$4.37M | 0.13% | 160 |
|